BHCM
VSTM icon

Brevan Howard Capital Management’s Verastem VSTM Stock Holding History

Brevan Howard Capital Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$271K Buy
51,158
+25,986
+103% +$160K ﹤0.01% 1690
2025
Q4 		$194K Buy
+25,172
New +$224K ﹤0.01% 1591
2024
Q2 		– Sell
-24,102
Closed -$285K – 1421
2024
Q1 		$285K Buy
+24,102
New +$278K ﹤0.01% 678

Other funds holding VSTM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brevan Howard Capital Management's VSTM Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Verastem (VSTM) stake by 103% in Q1 2026, buying an estimated $160K and bringing the position to 51,158 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #1690.

Brevan Howard Capital Management first reported a position in VSTM in Q1 2024 and has held it in 3 quarters since. The position peaked at $285K in Q1 2024. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • Brevan Howard Capital Management held 51,158 shares of Verastem worth $271K as of Q1 2026.
  • Brevan Howard Capital Management bought 25,986 Verastem shares in Q1 2026, an estimated $160K.
  • Verastem made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1690 holding.
  • Brevan Howard Capital Management first reported a position in Verastem in Q1 2024 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's Verastem position peaked at $285K in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.